-Live Mint An investigation found DCGI cleared drugs without conducting mandatory clinical trials After five rounds of consultations in six months, a committee tasked with making recommendations on cleaning up India’s drugs-approval process and ending the cosy relationship between doctors, pharmaceutical companies and government officials had no suggestions to offer by way of a crackdown. It has, instead, suggested setting up 20 sub-committees. The report submitted to the health ministry in November is...

-Pratirodh.com The fanfare with which Prime Minister Manmohan Singh and Congress president Sonia Gandhi launched a service delivery scheme in Rajasthan based on the Aadhaar (foundation) unique identity (UID), and celebrated the issue of the first Aadhaar number topping the 200-million mark, should make the Indian National Congress a very worried party indeed—assuming it has a good survival instinct and basic grasp of practical politics.    To put it starkly, the Congress and...

-Live Mint He is at the head of a march to Delhi for a new policy that promises every poor family a small patch of land Morena (Madhya Pradesh): One hot Friday in October, a 64-year-old man named P.V. Rajagopal is marching at the head of a procession of around 50,000 people on the highway from Gwalior to Delhi.   Rajagopal is slight and heavily sunburnt, and has walked tens of thousands of kilometres...

-The Hindu The government has issued a warning letter to Programme for Appropriate Technology in Health (PATH), asking it to be careful while conducting clinical trials so as to ensure that discrepancies and violations are not repeated in future. The Indian Council of Medical Research (ICMR) had suspended the Phase-V post licensure clinical trial being conducted by PATH, an international non-governmental organisation, in Khamman (Andhra Pradesh) and Vadodara (Gujarat) for Human Papilloma...

Regulations covering public health should override personal rights and the country cannot wait any more for a good public health law. The health care industry, including institutions of medical education, hospitals and pharmaceutical businesses, have grown into behemoths that can do considerable harm in the absence of independent and effective regulatory systems. While there are no success stories in the regulation of any kind of industry in India, I will focus...